Need immediate assistance? Call 1-518-730-0559 (Us-Canada Toll Free) or Contact Us

 

Cardiac Arrest Treatment Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 – 2027

Table of Content

1. Preface 
      1.1. Report Scope and Market Segmentation 
      1.2. Research Highlights

2. Assumptions and Research Methodology 
      2.1. Assumptions and Acronyms Used
      2.2. Research Methodology

3. Executive Summary
      3.1. Global Cardiac Arrest Treatment Market Size (US$ Mn) and Distribution, by Region, 2019 and 2027
      3.2. Global Cardiac Arrest Treatment Market: Market Snapshot

4. Market Overview
      4.1. Global Cardiac Arrest Treatment Market: Treatment Overview 
      4.2. Global Cardiac Arrest Treatment Market: Key Industry Developments
      4.3. Market Dynamics
      4.4. Drivers and Restraints Snapshot Analysis
      4.5. Drivers
             4.5.1. Rise in prevalence of congestive heart failure (CHF) 
             4.5.2. Government initiatives
      4.6. Restraints
             4.6.1. Low availability of cardiac arrest treatment in emerging countries
             4.6.2. Growth of the generic drugs industry
      4.7. Opportunities
      4.8. Global Cardiac Arrest Treatment Market Revenue Projections (US$ Mn), 2017–2027

5. Key Insights
      5.1. Incidence Rate of Cardiac Arrest In Key Countries
      5.2. Technological Advancements in Medical Devices for Cardiac Arrest Treatment 
      5.3. Treatment Usage Pattern (Three-Phase Model of Cardiac Arrest)
      5.4. Promising Treatments in Clinical Development: Cardiac Arrest 
      5.5. Annual cost of prehospital equipment per patient used to treat OHCA (Out- of Hospital Cardiac Arrest)
      5.6. Key Merger and Acquisition
      5.7. Research and Development Strategies for Key Companies 
      5.8. Pipeline Analysis for Cardiac Arrest Therapeutics

6. Global Cardiac Arrest Treatment Market Analysis, by Treatment
      6.1. Introduction
      6.2. Global Cardiac Arrest Treatment Market Size and Forecast, by Treatment
             6.2.1. Drugs
                      6.2.1.1. Vasopressors
                      6.2.1.2. Anti-arrhythmic Drugs
                      6.2.1.3. Anticholinergic Drugs
                      6.2.1.4. Corticosteroids
                      6.2.1.5. Fibrinolytic Drugs
                      6.2.1.6. Beta Blockers
                      6.2.1.7. Others (sodium bicarbonate, crystalloids, colloids, etc.)
             6.2.2. Medical Devices
                      6.2.2.1. Defibrillators
                      6.2.2.2. Cardiac Resynchronization Therapy (CRT)
                      6.2.2.3. Others
      6.3. Global Cardiac Arrest Treatment Market Analysis, by Treatment
      6.4. Global Cardiac Arrest Treatment Market Attractiveness Analysis, by Treatment

7. Global Cardiac Arrest Treatment Market Analysis, by Sales Channel
      7.1. Introduction
      7.2. Global Cardiac Arrest Treatment Market Size and Forecast, by Sales Channel
             7.2.1. Hospitals 
             7.2.2. Independent Pharmacies
             7.2.3. Others
      7.3. Global Cardiac Arrest Treatment Market Analysis, by Sales Channel
      7.4. Global Cardiac Arrest Treatment Market Attractiveness Analysis, by Sales Channel

8. Global Cardiac Arrest Treatment Market Analysis, by Region
      8.1. Global Cardiac Arrest Treatment Market Size and Forecast, by Region, 2017–2027 
             8.1.1. North America
             8.1.2. Europe
             8.1.3. Asia Pacific
             8.1.4. Latin America
             8.1.5. Middle East & Africa
      8.2. Global Cardiac Arrest Treatment Market Analysis, by Region
      8.3. Global Cardiac Arrest Treatment Market Attractiveness Analysis, by Region

9. North America Cardiac Arrest Treatment Market Analysis
      9.1. North America Cardiac Arrest Treatment Market 
      9.2. North America Cardiac Arrest Treatment Market Overview
      9.3. North America Cardiac Arrest Treatment Market Size and Forecast, by Treatment
             9.3.1. Drugs
                      9.3.1.1. Vasopressors
                      9.3.1.2. Anti-arrhythmic Drugs
                      9.3.1.3. Anticholinergic Drugs
                      9.3.1.4. Corticosteroids
                      9.3.1.5. Fibrinolytic Drugs
                      9.3.1.6. Beta Blockers
                      9.3.1.7. Others (sodium bicarbonate, crystalloids, colloids, etc.)
             9.3.2. Medical Devices
                      9.3.2.1. Defibrillators
                      9.3.2.2. Cardiac Resynchronization Therapy (CRT)
                      9.3.2.3. Others 
      9.4. North America Cardiac Arrest Treatment Market Size and Forecast, by Sales Channel 
             9.4.1. Hospitals 
             9.4.2. Independent Pharmacies
             9.4.3. Others
      9.5. North America Cardiac Arrest Treatment Market Forecast, by Country
             9.5.1. U.S.
             9.5.2. Canada
      9.6. North America Cardiac Arrest Treatment Market Attractiveness Analysis 
             9.6.1. By Treatment
             9.6.2. By Sales Channel
             9.6.3. By Country

10. Europe Cardiac Arrest Treatment Market Analysis
      10.1. Europe Cardiac Arrest Treatment Market 
      10.2. Europe Cardiac Arrest Treatment Market Overview
      10.3. Europe Cardiac Arrest Treatment Market Size and Forecast, by Treatment
             10.3.1. Drugs
                      10.3.1.1. Vasopressors
                      10.3.1.2. Anti-arrhythmic Drugs
                      10.3.1.3. Anticholinergic Drugs
                      10.3.1.4. Corticosteroids
                      10.3.1.5. Fibrinolytic Drugs
                      10.3.1.6. Beta Blockers
                      10.3.1.7. Others (sodium bicarbonate, crystalloids, colloids, etc.)
             10.3.2. Medical Devices
                      10.3.2.1. Defibrillators
                      10.3.2.2. Cardiac Resynchronization Therapy (CRT)
                      10.3.2.3. Others 
      10.4. Europe Cardiac Arrest Treatment Market Size and Forecast, by Sales Channel 
             10.4.1. Hospitals 
             10.4.2. Independent Pharmacies
             10.4.3. Others
      10.5. Europe Cardiac Arrest Treatment Market Forecast, by Country/Sub-region
             10.5.1. U.K.
             10.5.2. France
             10.5.3. Germany
             10.5.4. Spain
             10.5.5. Italy
             10.5.6. Rest of Europe
      10.6. Europe Cardiac Arrest Treatment Market Attractiveness Analysis 
             10.6.1. By Treatment
             10.6.2. By Sales Channel
             10.6.3. By Country/Sub-region

11. Asia Pacific Cardiac Arrest Treatment Market Analysis
      11.1. Asia Pacific Cardiac Arrest Treatment Market Key Findings
      11.2. Asia Pacific Cardiac Arrest Treatment Market Overview
      11.3. Asia Pacific Cardiac Arrest Treatment Market Size and Forecast, by Treatment
             11.3.1. Drugs
                      11.3.1.1. Vasopressors
                      11.3.1.2. Anti-arrhythmic Drugs
                      11.3.1.3. Anticholinergic Drugs
                      11.3.1.4. Corticosteroids
                      11.3.1.5. Fibrinolytic Drugs
                      11.3.1.6. Beta Blockers
                      11.3.1.7. Others (sodium bicarbonate, crystalloids, colloids, etc.)
             11.3.2. Medical Devices
                      11.3.2.1. Defibrillators
                      11.3.2.2. Cardiac Resynchronization Therapy (CRT)
                      11.3.2.3. Others 
      11.4. Asia Pacific Cardiac Arrest Treatment Market Size and Forecast, by Sales Channel 
             11.4.1. Hospitals 
             11.4.2. Independent Pharmacies
             11.4.3. Others
      11.5. Asia Pacific Cardiac Arrest Treatment Market Forecast, by Country/Sub-region
             11.5.1. China
             11.5.2. India
             11.5.3. Japan
             11.5.4. Australia & New Zealand
             11.5.5. Rest of Asia Pacific
      11.6. Asia Pacific Cardiac Arrest Treatment Market Attractiveness Analysis 
             11.6.1. By Treatment
             11.6.2. By Sales Channel
             11.6.3. By Country/Sub-region

12. Latin America Cardiac Arrest Treatment Market Analysis
      12.1. Latin America Cardiac Arrest Treatment Market Key Findings
      12.2. Latin America Cardiac Arrest Treatment Market Overview
      12.3. Latin America Cardiac Arrest Treatment Market Size and Forecast, by Treatment
             12.3.1. Drugs
                      12.3.1.1. Vasopressors
                      12.3.1.2. Anti-arrhythmic Drugs
                      12.3.1.3. Anticholinergic Drugs
                      12.3.1.4. Corticosteroids
                      12.3.1.5. Fibrinolytic Drugs
                      12.3.1.6. Beta Blockers
                      12.3.1.7. Others (sodium bicarbonate, crystalloids, colloids, etc.)
             12.3.2. Medical Devices
                      12.3.2.1. Defibrillators
                      12.3.2.2. Cardiac Resynchronization Therapy (CRT)
                      12.3.2.3. Others 
      12.4. Latin America Cardiac Arrest Treatment Market Size and Forecast, by Sales Channel 
             12.4.1. Hospitals 
             12.4.2. Independent Pharmacies
             12.4.3. Others
      12.5. Latin America Cardiac Arrest Treatment Market Forecast, by Country/Sub-region
             12.5.1. Brazil
             12.5.2. Mexico
             12.5.3. Rest of Latin America
      12.6. Latin America Cardiac Arrest Treatment Market Attractiveness Analysis 
             12.6.1. By Treatment
             12.6.2. By Sales Channel
             12.6.3. By Country/Sub-region

13. Middle East & Africa Cardiac Arrest Treatment Market Analysis
      13.1. Middle East & Africa Cardiac Arrest Treatment Market 
      13.2. Middle East & Africa Cardiac Arrest Treatment Market Overview
      13.3. Middle East & Africa Cardiac Arrest Treatment Market Size and Forecast, by Treatment
             13.3.1. Drugs
                      13.3.1.1. Vasopressors
                      13.3.1.2. Anti-arrhythmic Drugs
                      13.3.1.3. Anticholinergic Drugs
                      13.3.1.4. Corticosteroids
                      13.3.1.5. Fibrinolytic Drugs
                      13.3.1.6. Beta Blockers
                      13.3.1.7. Others (sodium bicarbonate, crystalloids, colloids, etc.)
             13.3.2. Medical Devices
                      13.3.2.1. Defibrillators
                      13.3.2.2. Cardiac Resynchronization Therapy (CRT)
                      13.3.2.3. Others 
      13.4. Middle East & Africa Cardiac Arrest Treatment Market Size and Forecast, by Sales Channel 
             13.4.1. Hospitals 
             13.4.2. Independent Pharmacies
             13.4.3. Others
      13.5. Middle East & Africa Cardiac Arrest Treatment Market Forecast, by Country/Sub-region
             13.5.1. GCC Countries
             13.5.2. South Africa
             13.5.3. Rest of Middle East & Africa
      13.6. Middle East & Africa Cardiac Arrest Treatment Market Attractiveness Analysis 
             13.6.1. By Treatment
             13.6.2. By Sales Channel
             13.6.3. By Country/Sub-region

14. Competition Landscape
      14.1. Company Profiles
             14.1.1. Amgen, Inc.
                      14.1.1.1. Overview (HQ, Employee Strength, Business Segments)
                      14.1.1.2. Financials
                      14.1.1.3. Recent Developments
                      14.1.1.4. Strategy
             14.1.2. Pfizer, Inc.
                      14.1.2.1. Overview (HQ, Employee Strength, Business Segments)
                      14.1.2.2. Financials
                      14.1.2.3. Recent Developments
                      14.1.2.4. Strategy
             14.1.3. Johnson & Johnson 
                      14.1.3.1. Overview (HQ, Employee Strength, Business Segments)
                      14.1.3.2. Financials
                      14.1.3.3. Recent Developments
                      14.1.3.4. Strategy
             14.1.4. Novartis AG
                      14.1.4.1. Overview (HQ, Employee Strength, Business Segments)
                      14.1.4.2. Financials
                      14.1.4.3. Recent Developments
                      14.1.4.4. Strategy
             14.1.5. Bristol-Myers Squibb Company 
                      14.1.5.1. Overview (HQ, Employee Strength, Business Segments)
                      14.1.5.2. Financials
                      14.1.5.3. Recent Developments
                      14.1.5.4. Strategy
             14.1.6. Abbott
                      14.1.6.1. Overview (HQ, Employee Strength, Business Segments)
                      14.1.6.2. Financials
                      14.1.6.3. Recent Developments
                      14.1.6.4. Strategy
             14.1.7. Bayer AG
                      14.1.7.1. Overview (HQ, Employee Strength, Business Segments)
                      14.1.7.2. Financials
                      14.1.7.3. Recent Developments
                      14.1.7.4. Strategy
             14.1.8.  Koninklijke Philips N.V
                      14.1.8.1. Overview (HQ, Employee Strength, Business Segments)
                      14.1.8.2. Financials
                      14.1.8.3. Recent Developments
                      14.1.8.4. Strategy
             14.1.9. GE Healthcare
                      14.1.9.1. Overview (HQ, Employee Strength, Business Segments)
                      14.1.9.2. Financials
                      14.1.9.3. Recent Developments
                      14.1.9.4. Strategy
             14.1.10. Physio-Control, Inc. (Stryker)
                      14.1.10.1. Overview (HQ, Employee Strength, Business Segments)
                      14.1.10.2. Financials
                      14.1.10.3. Recent Developments
                      14.1.10.4. Strategy
             14.1.11. Boston Scientific Corporation
                      14.1.11.1. Overview (HQ, Employee Strength, Business Segments)
                      14.1.11.2. Financials
                      14.1.11.3. Recent Developments
                      14.1.11.4. Strategy
             14.1.12. Cardiac Science Corporation (Aurora Capital Group)
                      14.1.12.1. Overview (HQ, Employee Strength, Business Segments)
                      14.1.12.2. Financials
                      14.1.12.3. Recent Developments
                      14.1.12.4. Strategy
             14.1.13. Shenzhen Mindray Bio-Medical Electronics Co., Ltd
                      14.1.13.1. Overview (HQ, Employee Strength, Business Segments)
                      14.1.13.2. Financials
                      14.1.13.3. Recent Developments
                      14.1.13.4. Strategy

Custom Market Research Services

MRRSE offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

Get A Free Custom Research Quote